Opportunities and Evolution of Biomaterials in Orthopaedics
Theodore Clineff, Vice President of Orthobiologics Research & Product Development, Stryker
ABSTRACT
Medical devices have evolved in order to better treat orthopaedic injuries. The demands for more
durable, higher quality orthopaedic medical devices and improved patient outcomes have
stimulated competition within our industry. The stimulation of new medical device technology has
created novel significant products including ultra-low wear polyethylene bearing surfaces for total
joint reconstruction, silver coated external fixation for antibacterial purposes and biologic bone
grafts for spine fusion.
The objective of this study was to demonstrate the impact of the orthopedic medical device has
had on society and created a new field of Orthobiologics research and development.
BIOGRAPHY
Theodore (Ted) Clineff is a bioengineer working in medical device industry for the last 13
years. His primary focus has been developing biomaterials for both cortical and cancellous bone
repair. The vast majority of his experience has been with Orthovita, a startup medical device
company who was acquired by Stryker in June, 2011. While at Orthovita, he embraced and
developed technology and then led various products to commercialization in both US and
abroad. Ted's education background includes BS in Engineering Science from Penn State
University, MS in Bioengineering from University of Pittsburgh and an MBA from Penn State
University. Ted is husband to Amy and father to three children with a fourth addition expected in
June.